Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling

Oncotarget

Volumn 6, Issue 34, 2015, Pages 35830-35842

  Zhang, Wei ^a   Levi, Liraz ^a   Banerjee, Pallab ^b   Jain, Mukesh ^c   Noy, Noa ^a,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Kruppel like factor; Nuclear receptors; Retinoic acid; Vitamin A

Indexed keywords

BINDING PROTEIN; CELLULAR RETINOIC ACID BINDING PROTEIN 2; FATTY ACID BINDING PROTEIN 5; KRUPPEL LIKE FACTOR 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; RETINOIC ACID; RETINOIC ACID RECEPTOR; UNCLASSIFIED DRUG; FABP5 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; KLF2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; RETINOIC ACID BINDING PROTEIN II, CELLULAR; RETINOIC ACID RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BREAST TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION; GENETIC TRANSCRIPTION; GENETICS; MCF-7 CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; FATTY ACID-BINDING PROTEINS; FEMALE; HETEROGRAFTS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MCF-7 CELLS; MICE; MICE, NUDE; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRETINOIN;

EID: 84946866918     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5767     Document Type: Article

References (50)

1. Black AR, Black JD and Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. Journal of cellular physiology. 2001; 188:143-160.
2. Kaczynski J, Cook T and Urrutia R. Sp1-and Kruppel-like transcription factors. Genome biology. 2003; 4:206.
3. Liu R, Zheng HQ, Zhou Z, Dong JT and Chen C. KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization. The Journal of biological chemistry. 2009; 284:16791-16798.
4. Frigo DE, Sherk AB, Wittmann BM, Norris JD, Wang Q, Joseph JD, Toner AP, Brown M and McDonnell DP. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. Molecular endocrinology. 2009; 23:1385-1396.
5. Dang DT, Chen X, Feng J, Torbenson M, Dang LH and Yang VW. Overexpression of Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene. 2003; 22:3424-3430.
6. Fernandez-Zapico ME, Lomberk GA, Tsuji S, DeMars CJ, Bardsley MR, Lin YH, Almada LL, Han JJ, Mukhopadhyay D, Ordog T, Buttar NS and Urrutia R. A functional familywide screening of SP/KLF proteins identifies a subset of suppressors of KRAS-mediated cell growth. The Biochemical journal. 2011; 435:529-537.
7. Fernandez-Zapico ME, Mladek A, Ellenrieder V, Folch-Puy E, Miller L and Urrutia R. An mSin3A interaction domain links the transcriptional activity of KLF11 with its role in growth regulation. The EMBO journal. 2003; 22:4748-4758.
8. Kremer-Tal S, Narla G, Chen Y, Hod E, DiFeo A, Yea S, Lee JS, Schwartz M, Thung SN, Fiel IM, Banck M, Zimran E, Thorgeirsson SS, Mazzaferro V, Bruix J, Martignetti JA, et al. Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. Journal of hepatology. 2007; 46:645-654.
9. Duhagon MA, Hurt EM, Sotelo-Silveira JR, Zhang X and Farrar WL. Genomic profiling of tumor initiating prostatospheres. BMC genomics. 2010; 11:324.
10. Wang F, Zhu Y, Huang Y, McAvoy S, Johnson WB, Cheung TH, Chung TK, Lo KW, Yim SF, Yu MM, Ngan HY, Wong YF and Smith DI. Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis. Oncogene. 2005; 24:3875-3885.
11. Wu J and Lingrel JB. KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1. Oncogene. 2004; 23(49):8088-8096.
12. Bhattacharya R, Senbanerjee S, Lin Z, Mir S, Hamik A, Wang P, Mukherjee P, Mukhopadhyay D and Jain MK. Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. The Journal of biological chemistry. 2005; 280:28848-28851.
13. Kannan-Thulasiraman P, Seachrist DD, Mahabeleshwar GH, Jain MK and Noy N. Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth. The Journal of biological chemistry. 2010; 285:19106-19115.
14. Berry DC, DeSantis D, Soltanian H, Croniger CM and Noy N. Retinoic acid upregulates preadipocyte genes to block adipogenesis and suppress diet-induced obesity. Diabetes. 2012; 61:1112-1121.
15. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 1996; 10:940-954.
16. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, De Lera AR, Lotan R, Mangelsdorf DJ and Gronemeyer H. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev. 2006; 58:712-725.
17. Schug TT, Berry DC, Shaw NS, Travis SN and Noy N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell. 2007; 129:723-733.
18. Shaw N, Elholm M and Noy N. Retinoic acid is a high affinity selective ligand for the peroxisome proliferatoractivated receptor beta/delta. The Journal of biological chemistry. 2003; 278:41589-41592.
19. Tan NS, Shaw NS, Vinckenbosch N, Liu P, Yasmin R, Desvergne B, Wahli W and Noy N. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Molecular and cellular biology. 2002; 22:5114-5127.
20. Sessler RJ and Noy N. A ligand-activated nuclear localization signal in cellular retinoic acid binding proteinII. Molecular cell. 2005; 18:343-353.
21. Armstrong EH, Goswami D, Griffin PR, Noy N and Ortlund EA. Structural basis for ligand regulation of the Fatty Acid Binding Protein 5, Peroxisome Proliferator Activated Receptor beta/delta (FABP5-PPARbeta/delta) signaling pathway. The Journal of biological chemistry. 2014;289:14941-54.
22. Budhu AS and Noy N. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Molecular and cellular biology. 2002; 22:2632-2641.
23. Dong D, Ruuska SE, Levinthal DJ and Noy N. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. The Journal of biological chemistry. 1999; 274:23695-23698.
24. Budhu A, Gillilan R and Noy N. Localization of the RAR interaction domain of cellular retinoic acid binding proteinII. J Mol Biol. 2001; 305:939-949.
25. Donato LJ and Noy N. Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling. Cancer research. 2005; 65:8193-8199.
26. Donato LJ, Suh JH and Noy N. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. Cancer research. 2007; 67:609-615.
27. Noy N. Between death and survival: retinoic acid in regulation of apoptosis. Annual review of nutrition. 2010; 30:201-217.
28. Afonja O, Juste D, Das S, Matsuhashi S and Samuels HH. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene. 2004; 23:8135-8145.
29. Afonja O, Raaka BM, Huang A, Das S, Zhao X, Helmer E, Juste D and Samuels HH. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition. Oncogene. 2002; 21:7850-7860.
30. Zacheis D, Dhar A, Lu S, Madler MM, Klucik J, Brown CW, Liu S, Clement F, Subramanian S, Weerasekare GM, Berlin KD, Gold MA, Houck JR, Jr., Fountain KR and Benbrook DM. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors. Journal of medicinal chemistry. 1999; 42:4434-4445.
31. Soprano DR, Qin P and Soprano KJ. Retinoic Acid Receptors and Cancers. Annual review of nutrition. 2004; 24:201-221.
32. Adachi Y, Itoh F, Yamamoto H, Iku S, Matsuno K, Arimura Y and Imai K. Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2001; 22:247-253.
33. Di-Poi N, Michalik L, Tan NS, Desvergne B and Wahli W. The anti-apoptotic role of PPARbeta contributes to efficient skin wound healing. J Steroid Biochem Mol Biol. 2003; 85:257-265.
34. Di-Poi N, Tan NS, Michalik L, Wahli W and Desvergne B. Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Molecular cell. 2002; 10:721-733.
35. Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B and Ichikawa H. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Annals of the New York Academy of Sciences. 2006; 1091:151-169.
36. Montagner A, Delgado MB, Tallichet-Blanc C, Chan JS, Sng MK, Mottaz H, Degueurce G, Lippi Y, Moret C, Baruchet M, Antsiferova M, Werner S, Hohl D, Saati TA, Farmer PJ, Tan NS, et al. Src is activated by the nuclear receptor peroxisome proliferator-activated receptor beta/delta in ultraviolet radiation-induced skin cancer. EMBO molecular medicine. 2014; 6:80-98.
37. Wang D, Wang H, Guo Y, Ning W, Katkuri S, Wahli W, Desvergne B, Dey SK and DuBois RN. Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 2006; 103:19069-19074.
38. Manor D, Shmidt EN, Budhu A, Flesken-Nikitin A, Zgola M, Page R, Nikitin AY and Noy N. Mammary carcinoma suppression by cellular retinoic acid binding protein-II. Cancer research. 2003; 63:4426-4433.
39. Schug TT, Berry DC, Toshkov IA, Cheng L, Nikitin AY and Noy N. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105:7546-7551.
40. Levi L, Lobo G, Doud MK, von Lintig J, Seachrist D, Tochtrop GP and Noy N. Genetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesis. Cancer research. 2013; 73:4770-4780.
41. Morgan E, Kannan-Thulasiraman P and Noy N. Involvement of Fatty Acid Binding Protein 5 and PPARbeta/delta in Prostate Cancer Cell Growth. PPAR Res. 2010; 2010.
42. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Graf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, et al. The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups. Nature. 2012; 486:346-352.
43. TCGA. The Cancer Genome Atlas, http://tcga-data.nci.nih.gov/tcga/.2011.
44. Sussman F and de Lera AR. Ligand recognition by RAR and RXR receptors: binding and selectivity. Journal of medicinal chemistry. 2005; 48:6212-6219.
45. Levi L, Lobo G, Doud MK, von Lintig J, Seachrist D, Tochtrop GP and Noy N. Genetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesis. Cancer research. 73:4770-4780.
46. Ray WJ, Bain G, Yao M and Gottlieb DI. CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. The Journal of biological chemistry. 1997; 272:18702-18708.
47. White JA, Ramshaw H, Taimi M, Stangle W, Zhang A, Everingham S, Creighton S, Tam SP, Jones G and Petkovich M. Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. Proceedings of the National Academy of Sciences of the United States of America. 2000; 97:6403-6408.
48. Tan NS, Michalik L, Noy N, Yasmin R, Pacot C, Heim M, Fluhmann B, Desvergne B and Wahli W. Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes & development. 2001; 15:3263-3277.
49. Das H, Kumar A, Lin Z, Patino WD, Hwang PM, Feinberg MW, Majumder PK and Jain MK. Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proceedings of the National Academy of Sciences of the United States of America. 2006; 103:6653-6658.
50. Mitri Z, Constantine T and O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemotherapy research and practice. 2012; 2012:743193